Accéder au contenu
Merck
  • Development and validation of an ion-pair reversed-phase high-performance liquid chromatographic method for the separation of phosphonodipeptides.

Development and validation of an ion-pair reversed-phase high-performance liquid chromatographic method for the separation of phosphonodipeptides.

Journal of chromatography. B, Biomedical sciences and applications (1997-04-11)
N Surendran, C J Stankovic, B H Stewart
RÉSUMÉ

The objective of this research was to develop a rapid, sensitive and reliable method for the separation of phosphonodipeptide prodrugs and parent compounds to facilitate the evaluation of cell permeation using in vitro cell culture models. Separation was accomplished isocratically within 10.0 min using a C18 (150x4.6 mm I.D., 3 microm) reversed-phase column. The mobile phase consisted of 5 mM tetrahexyl ammonium (ion-pair reagent) in 0.02 M phosphate buffer pH 6.5-acetonitrile (48.5:51.5, v/v). The flow-rate was 1.1 ml/min with detection at 221 nm. The standard curves were linear (r2>0.999) over the concentration range 1-100 microM. The method was reliable and reproducible, with the limit of quantitation being 1 microM (25 ng on column).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Hydrogénosulfate de tétrahexylammonium, ≥98.0% (T)
Sigma-Aldrich
Bromure de tétrahexylammonium, 99%
Sigma-Aldrich
Tetrahexylammonium hydroxide solution, ~40% in H2O (T)
Sigma-Aldrich
Tetrahexylammonium chloride, 96%
Supelco
Hydrogénosulfate de tétrahexylammonium, suitable for ion pair chromatography, LiChropur, ≥99.0% (T)
Supelco
Bromure de tétrahexylammonium, suitable for ion pair chromatography, LiChropur, ≥99.0% (AT)